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Abstract
Foot-and-mouth disease virus (FMDV) causes a highly contagious disease in cloven-hoofed
animals. A synthetic vaccine candidate consisting of dendrimeric peptides harbouring two
copies of a B-epitope [VP1(136–154)] linked to a T-cell epitope [3A(21–35)] of FMDV con-
fers protection to type O FMDV challenge in pigs. Herein we show in cattle that novel dendri-
meric peptides bearing a T-cell epitope [VP1(21–40] and two or four copies of a B-cell
epitope [VP1(135–160)] from type O1 Campos FMDV (termed B2T and B4T, respectively)
elicited FMDV specific immune responses to similar levels to a commercial vaccine. Animals
were challenged with FMDV and 100% of vaccinated cattle with B2T or B4T were protected
to podal generalization. Moreover, bovines immunized with B4T were completely protected
(with no clinical signs) against FMDV challenge after three vaccine doses, which was asso-
ciated with titers of viral neutralizing antibodies in serum higher than those of B2T group (p<
0.05) and levels of opsonic antibodies similar to those of animals immunized with one dose
of FMDV commercial vaccine. Bovines vaccinated with both dendrimeric peptides pre-
sented high levels of IgG1 anti FMDV in sera and in mucosa. When IgA in nasal secretions
was measured, 20% or 40% of the animals in B2T or B4T groups respectively, showed anti-
FMDV IgA titers. In addition, B2T and B4T peptides evoked similar consistent T cell
responses, being recognized in vitro by lymphocytes from most of the immunized cattle in
the proliferation assay, and from all animals in the IFN-γ production assay. Taken together,
these results support the potential of dendrimers B2T or B4T in cattle as a highly valuable,
cost-effective FMDV candidate vaccine with DIVA potential.
Introduction
Foot-and-Mouth disease virus (FMDV) is a Picornavirus belonging to the genus Aphthovirus.
The viral particle consists of a positive-strand RNA genome encoding four capsid proteins,
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VP1, VP2, VP3 and VP4, and eleven different mature non-structural proteins, NSP-3A among
them [1]. FMDV has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2,
SAT3 and Asia 1. This virus produces a highly transmissible and devastating disease of farm
animals, foot-and-mouth Disease (FMD), which is the most feared animal disease worldwide,
causing large economic losses during an outbreak.
There is great disparity in progress towards FMD control and eradication. While some
countries are either FMD free or well on the road to achieving eradication, others are at an
early stage of FMD control. In endemic areas, such as Asia Africa and South America, FMD
control is performed by regular vaccination based on inactivated whole-virus. [1]. The limita-
tions shown by these conventional vaccines have prompted the study of new, safer alternative
vaccines [2]. Synthetic peptides are one of the most promising vaccine candidates for infec-
tious disease, such as FMD, as they are highly pure, defined, stable and safe. Moreover, recent
studies have shown that synthetic peptides achieve protective immunity against challenge in
swine [3, 4]. On the other hand, differentiation between vaccinated from infected animals is
feasible with such vaccines.
Linear peptides containing an immunodominant B-cell site located in the GH loop around
at positions 140–160 of capsid protein VP1 [5, 6] can protect against FMDV challenge. How-
ever, the protection conferred by these peptides is limited due, among other factors, to the lack
of T-cell epitopes [5, 7]. Therefore, an effective peptide vaccine needs multivalency of B-cell
epitopes to elicit a high neutralizing antibody response and T-cell epitopes that provide ade-
quate cooperation [8]. Multiple antigenic peptides (MAPs), also named dendrimers, are radial
or wedge-like branched macromolecules that contain a peptide core attached to a define num-
ber of epitopes [9, 10]. Pigs vaccinated with a dendrimeric peptide, which included the T-cell
epitope 21–35 from 3A and four copies of the B-cell site VP1 [136–154], were protected against
type C FMDV challenge [3]. Recent studies indicated that a similar construct incorporating
the B cell site sequence from type O FMDV O-UKG induced full protection in pigs [4].
In this report, novel dendrimeric peptides were designed containing a bovine T-cell epitope
21–40 from VP1 [11] linked to two (B2T) or four (B4T) copies of the B-cell site VP1 [135–160]
from FMDV O1 Campos assembled using a maleimide conjugation. A pilot study was per-
formed to address the immunogenicity of such dendrimeric vaccines and the protection
afforded in cattle against viral challenge.
Our results show for the first time that not only tetravalent presentation of B-cell epitopes
linked to the T-bovine epitope but also bivalent formulation results in an effective vaccine that
conferred protection in cattle. Thus, these synthetic peptides can be considered promising vac-
cine candidates with reasonable prospects of clinical application.
Materials and methods
Dendrimeric peptides
Two peptides (Fig 1) incorporating a T-cell epitope [VP1 (21–40)] immunodominant for
bovine lymphocytes [11, 12] and two or four copies of the B-cell epitope [site A–VP1 (135–
160)], termed B2T or B4T, respectively, in a dendrimeric arrangement were synthesized as
described [4, 13]. The C-terminal Cys side chain thiol is linked to Lys via a 3-maleimidopro-
pionic acid unit; the peptides were purified by HPLC and characterized by mass spectrometry.
Sequences are derived from FMDV O1 Campos.
Virus
FMDV O1 Campos was kindly provided by Biogenesis Bagó S.A. as binary ethylene-imine
(BEI)-inactivated (iFMDV). Purified virus was obtained by a sucrose density gradient
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centrifugation method [14] and was used for ELISA and lymphoproliferation assay. For chal-
lenging and virus neutralization assays, infective virus (kindly donated by the Argentine
National Service of Animal Health) was used in BSL-4 OIE laboratories and boxes at INTA.
Animals, vaccines, immunization and infection of cattle
Eighteen Hereford calves serologically negative for FMDV, approximately 6 months old, were
used in the experiment. Groups of five animals were inoculated twice (day 0 and 18) by
Fig 1. Dendrimeric peptides used in this study.
https://doi.org/10.1371/journal.pone.0185184.g001
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subcutaneous injection in the front left quarter with 2 mg of B2T or B4T peptide in 2 ml of a
water-in-oil single emulsion. The adjuvant included was MONTANIDE ISA 50 V (Seppic). At
38 dpv animals were boosted with 0.5 mg of B2T or B4T peptide. Forty-six days after the first
vaccination, immunized animals as well as 3 control unvaccinated bovines were challenged by
nasal instillation with 1 ml (0.5 ml for each nostril) of a 104 suckling mouse lethal doses 50%
equivalent to 104 Bovine Infective Doses 50% (BID50) of infective FMDV O1 Campos (deter-
mined by titration on cattle tongue) [15–17]. This method mimics a natural FMDV infection
[18]. Control unvaccinated bovine (n = 3) were challenged at the same time and following the
same procedure. Seven days post challenge (dpc) all animals were checked for FMDV-induced
lesions on feet, mouth and tongue. Animals with absence of FMDV lesions at the feet were
considered protected against podal generalization (PPG). Another five calves were immunized
by subcutaneous injection with a single dose of commercial FMDV vaccine, a water in oil sin-
gle emulsion containing FMDV strains A Arg 2000, A Arg 2001; A24 Cruzeiro and O1 Cam-
pos. This vaccine had been approved by the Argentine Animal Health Service (SENASA) with
more than 80% of expected percentage of protection against each of the viruses included in its
formulation [19]. This group was used as a control of immune response quality. Experiments
were carried out according to INTA Ethics Manual “Guide for the use and care of experimen-
tal animals”. The protocol was approved by the Institutional Animal care and use Committee
“Comité Institucional para el cuidado y uso de animales de experimentación” CICUAE INTA
CICVyA (Permit Number: 77/2013).
Measurement of anti FMDV antibodies
An indirect ELISA was used for anti-dendrimer antibodies measurement. Maxisorp 96-well
plates (Nunc) were coated with B4T peptide (30μg/ml), plates were washed and blocked with
PBST-OVA 1% and dilutions of serum samples were added. After incubation, plates were
washed and horseradish peroxidase (HRP) labeled goat anti-bovine IgGs antibody (KPL,
USA) was added. After washing, ortho-phenylenediamine (OPD)-H2O2 was added as HRP
substrate. FMDV-specific antibodies were detected by means of an indirect ELISA, as
described [20]. Briefly, Immulon II 96-well ELISA plates were coated with 2.6 μg/ml FMDV
O1Campos and processed as described above.
The antiviral ELISA detailed above was modified in order to detect FMDV-specific IgG1,
IgG2 (in sera), and IgG1, IgA (in nasal swabs) antibodies [20, 21]. After incubation with sam-
ples, a mouse anti-bovineIgG1, IgG2 or IgA monoclonal antibody was added (kindly provided
by Dr. S. Srikumaran, University of Nebraska, USA). Lastly, a (HRP) labeled goat anti-mouse
IgG antibody was added after wash. OPD was used as HRP substrate. Absorbance was
recorded at 492nm (A492) in a microplate photometer (Multiskan FC, Thermo). The cut-off
was established as the mean A492 of the negative sera (from 5 unvaccinated animals) plus two
standard deviations (SD). Antibody titers were calculated as log 10 of last reciprocal dilution
above cut-off. Positive control sera were included in every plate.
Opsonophagocytosis assay
Inactivated FMDV (iFMDV) was labeled with FITC (Sigma, St. Louis,MO) as described [22].
Briefly, FITC-iFMDV was incubated with serum and added to bovine macrophage cells
(BoMac) [23]. Prior to inactivation, the virus was titrated, by Reed and Müench method, in
order to incubate the BoMac cells with a quantity of virus representing a multiplicity of infec-
tion of 10. Extracellular fluorescence was quenched with Trypan Blue. The ability of the anti-
bodies to opsonize viral particles was analyzed by flow cytometry, using a FACSCalibur
(Becton Dickinson, San Jose, CA) and CellQuest software. Results were expressed as % of
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BoMac cells incorporating FITC-iFMDV after incubation with sera. The cut-off was calculated
as the mean percentage of BoMac cells incorporating FITC-iFMDV incubated with five nega-
tive sera, plus 2 SD.
Percentage of FMDV neutralization
The percentage of virus neutralized by serum from immunized cattle, at 38 and 44dpv (upon 2
and 3 peptide doses, respectively) was measured as previously describe [24] with minor modi-
fications. Briefly, a 1/8 serum dilution was incubated with different 10-fold dilutions of infec-
tive FMDV (1000 to 1 TCID50), and the infective virus recovered was determined by a TCID50
assay. Titers were expressed as the % of the initial virus neutralized upon incubation. Signifi-
cant differences are indicate as  (p<0.001).
Serum Neutralization titer
Serum samples were examined for anti-FMDV neutralizing antibodies (fixed virus, variable
serum) as described before [20]. Briefly, serial dilutions of inactivated sera were incubated for
1 h at 37˚C with 100 TCID50 of infective FMDV. Then virus-serum mixtures were seeded on
BHK-21 monolayers. After 40 min at 37˚C, fresh medium supplemented with 2% FCS was
added to the cells that were incubated at 37˚C under 5% CO2. Cytopathic effects were observed
after 48 h. Titers of virus neutralizing antibodies were expressed as log10 of the reciprocal of
the serum dilution which neutralize 50% of 100 FMDV DICT50.
Lymphoproliferation assay
Peripheral blood mononuclear cells (PBMC) were obtained from cattle as described [25] and
2x107 cell/ml were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) 3 μM
in PBS for 15 min at 37˚C. Labeled cells were added to 96-well plate (5 x 105 cell/well) contain-
ing (i) 5μg/ml iFMDV, (ii) 50μg/ml of peptides B2T, B4T or T, and (iii) 5μg/ml Concanavalin
A (Sigma–Aldrich, S t. Louis, MO). Cells were incubated at 37˚C in 5% CO2 atmosphere 5
days, then 0.2% paraformaldehyde was added and cell proliferation was analyzed by flow
cytometry. Results were expressed as %CFSE proliferation. The cut-off was the mean % CFSE
proliferation in wells without stimuli plus 2 SD.
IFN-γ detection
PBMC were cultured with 50μg/ml of B2T, B4T or T peptides for 72 h. Supernatants were ana-
lyzed using ELISA as described previously [20]. Briefly, plates were coated with a mAb against-
IFN-γ (kindly donated by Dr. L. Babiuk). Samples and recombinant IFN-γ standard (Serotec,
UK) were added and IFN was detected using rabbit polyclonal anti-IFN-γ antibodies. After
incubation, biotinylated goat anti-rabbit IgG antibody was added and then, HRP-conjugated
streptavidin (KPL, USA). Plates were washed, incubated with (OPD)-H2O2 and read at
492nm. IFN-γ concentration was calculated from interpolation of data in the standard curve.
RNA extraction and PCR amplification of viral RNA
Samples were obtained from lesions of the disease on tongue and viral RNA was extracted
using Trizol (Invitrogen) and used as template of a reverse transcription reaction performed
with random primers. The resulting cDNA was used to carry out PCR amplification of, on the
one hand, the FMDV 3D polymerase gene (primers: GK2 -antisense- CTAGACCGTGTTGG
TGGGTT and GK7 -sense- CCGACCACCACGGTGTTTTCG) and of host 18S ribosomal RNA as
internal control. Amplicons of 380 bp and 480 bp were obtained for 3D viral polymerase and
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host rRNA, respectively. On the order hand, PCR amplification of FMDV VP1 gene (primers:
P12B -antisense- TTCGAAGTACCAGGGTTTGGC and ALFA1 -sense- CTCGTTCATCATGGA
CAGATT). Amplicons of 780pb were obtained and direct sequencing of the PCR products was
performed by capillary electophoresis.
2.11 Statistical analysis
One-way analysis of variance (ANOVA) and Bonferroni post-tests were used to compare data
between three or more groups.
Results
B2T and B4T design and synthesis
B2T and B4T were designed as novel vaccine candidates as described in Fig 1. These new for-
mulations displayed either two or four copies of the B-cell epitopes VP1 [135–160] [26]
together with a single copy of the bovine T-cell epitope VP1 [21–40] [11, 12] both derived
from FMDV O1 Campos and were produced as described in 2.1.
B2T and B4T induce anti-peptide and FMDV specific antibodies
All animals inoculated with either B2T or B4T constructs developed specific and pronounced
anti-peptide as well as anti-FMDV total IgG and IgG1 responses (Fig 2A, 2B and 2C), includ-
ing animal 263 that showed increased levels of antibodies against FMDV after the third peptide
dose (Fig 2B). Bovines 257 and 264 (B2T) presented high levels of IgG1 only after the second
peptide dose (Fig 2C). At 44dpv, high anti-FMDV IgGs titers were detected in all animals (3.9
±0.1 and 4.0±0.2 in B2T and B4T groups, respectively) (Fig 2B). Low levels of specific FMDV
IgG2 were detected in both B2T and B4T groups with average antibody titers of 1.36±0.25 and
1.5±0.4, respectively (data not shown).
FMDV-specific mucosal immunity
Animals from B2T and B4T groups exhibited also high levels of anti-FMDV IgG1 in nasal
secretions at 28dpv, with exception of bovine 263 that only showed high IgG1 titers (7±1.0)
after the third immunization. When IgA was measured in nasal secretions, 1 out of 5 animals
in the B2T and 2 out of 5 in the B4T group, showed anti-FMDV IgA titers (Fig 2D) indicating
that these novel peptide constructs were able to induce not only systemic but also local muco-
sal immunity.
Analysis of the opsonic capacity of the sera
The importance of antibodies in FMD protection might be related to their ability to opsonize
rather than to neutralize viral particles [27, 28]. The average values of opsono-phagocytosis of
sera collected at the day of challenge (44dpv) were 24±11% in B2T group, 31±14% in B4T
group and 35±6% in cattle immunized with an FMDV commercial vaccine (Fig 3). These val-
ues were significantly higher than those of sera before immunization (negative controls; 15
±2%). In the B2T group, sera from 2 of the 5 animals showed significant responses, while 4 of
the 5 animals in the B4T group responded positively. In general, a trend towards higher opso-
nization values was observed in sera from animals immunized with the B4T construct, simi-
larly as the ones induced with the commercial vaccine.
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Analysis of the neutralizing capacity of the sera
We first determined the percentage of virus neutralized by a 1/8 dilution of sera from immu-
nized cattle. At 38dpv, the average values were 29±3% in animals from B2T group and 26
±10% in those from B4T group (Fig 4). However, when a virus neutralization test (VNT) was
performed to detect the antibody dilution capable of neutralizing a fixed amount of virus, no
serum sample at 38dpv was able to neutralize 100 TCID50 of FMDV O1Campos (VNT<0.9)
(data not shown), supporting a weak induction of neutralizing antibodies in these animals.
Taking into account these results, a third dose of each construct was administered to the
calves that resulted in a significant increase at 44 dpv in the neutralizing capacity of sera
(p<0.001) (Fig 4), being the percentages of neutralization 44±3% and 46±3% for animals in
B2T and B4T groups, respectively. Remarkably, these values were similar to those of a bovine
immunized with a single dose of commercial vaccine (45±10%). Interestingly, all animals
were also positive for VNT, being the mean titers of antibodies in animals from B4T group
(1.7±0.3) significantly higher (p<0.05) than those from B2T group (1.4±0.1). Again, these
VNT values were similar to those observed in animals vaccinated with commercial vaccine
(1.9±0.6) (Table 1).
Fig 2. Antibody detection by ELISA in vaccinated cattle. Animals were immunized on day 0, 18 and 38 (arrow) with B2T or B4T
vaccine. (A) Kinetics of anti-peptide serum antibodies. (B, C) Kinetics of total IgG anti-FMDV and IgG1 anti-FMDV serum antibodies.
Titers were calculated as log 10 of last reciprocal dilution above cut-off. (D) FMDV-specific mucosal IgG1 and IgA response. Nasal swabs
were collected at 28dpv. Each point represents the nasal IgG1 or IgA anti-FMDV antibody titers (log10) of each animal. Cut-off was
established as the mean value of mock vaccinated animals plus twice the standard deviation value.
https://doi.org/10.1371/journal.pone.0185184.g002
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Fig 3. Opsonising capacity of sera (from 44 dpv) measured by flow cytometry. Results are expressed as the % of BoMac cells
incorporating FITC-virus after incubation with sera from B2T, B4T, commercial vaccine or negative sera. Each bar represents the mean
of opsonising capacity of sera + SEM. * and *** represents significant differences (p<0.05 or p<0.001, respectivelly) compared to
opsonising capacity of negative sera (from day 0). The cut-off was calculated as the mean percentage of cells incubated with
FITC-FMDV- and sera free of FMDV antibodies plus 2 SD. The number of positive sera/ the total number of sera analyzed are indicated
above bars.
https://doi.org/10.1371/journal.pone.0185184.g003
Fig 4. Neutralization of FMDV O1Campos by sera from vaccinated animals. (A) % of virus neutralized by serum from
cattle immunized with B2T, B4T or a single dose of conventional vaccine, at 38 and 44dpv (upon 2 and 3 doses of peptide,
respectively). A 1/8 serum dilution was incubated with different doses of FMDV O1 Campos, and the infective virus recovered
was determined by a TCID50 assay. Titers are expressed as the % of the initial virus neutralized upon incubation. Significant
differences from dose are indicate as ***(p<0.001).
https://doi.org/10.1371/journal.pone.0185184.g004
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Specific cellular immune response and IFN-γ release in vaccinated
animals
Before challenge, at 44dpv, specific in vitro lymphoproliferations were conducted using several
stimuli. Significant values of proliferation (% CFSE proliferation4) to the peptide used for
immunization were found in 4 out of 5 animals of B2T group and in all the five animals from
B4T group (Table 2A). Responses to dendrimers (B2T or B4T) not used for immunization were
similar to those achieved with the immunizing peptide while the number of animals that rec-
ognized the T cell peptide alone was lower. In group B2T, PBMC from bovines 256 and 257 sig-
nificantly proliferated in response to the T peptide and animal 267 showed no response to any
stimulus. In group B4T only cells from bovine 263 and 271 proliferated when were stimulated
with the T peptide. PBMC from a negative control animal (Table 2A) and from all bovines at
day 0 did not respond to any peptide (data not shown).
Levels of IFN-γ secreted by PBMCs from immunized animals were also determined at
44dpv (Table 2B). Positive IFN-γ responses were found in 4 out of 5 animals of B2T group and
in all animals of B4T group following Ag-B2T stimulation. Whereas, Ag-B4T induced IFN-γ
secretion in PBMCs from 3 animals of B2T group and from 4 animals belonging to the B4T
group. In group B2T, only cells from bovine 256 and 257 secreted IFN-γ when they were stim-
ulated with the T peptide, whereas only PBMCs from bovine 263 from group B4T animals rec-
ognized this peptide for IFN-γ secretion.
B2T and B4T protect cattle against viral challenge
Subsequently, all animals were challenged at 44dpv by nasal instillation with infective FMDV
O1 Campos and protection was measured by monitoring clinical signs in animals after
Table 1. Virus neutralizing titers pre-challenge of cattle.
Group Animal n˚ VNT (44dpv) Mean VNT















Negative control 254 <0.9 <0.9
241 <0.9
261 <0.9
Titer of virus-neutralizing antibody at day 44 post vaccination. Titers were expressed as log10 of the reciprocal of the serum dilution which neutralize 50% of
100 DICT 50 of FMDV
https://doi.org/10.1371/journal.pone.0185184.t001
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challenge. As shown in Table 3, the three negative control animals showed typical FMDV
lesions while, remarkably, all B2T and B4T vaccinated bovines were protected against podal
generalization. Only animals 257 and 264, belonging to B2T group showed a single vesicle in
tongue at 7dpc even though they were PPG. These two lesions were positive for FMDV RNA
detection by RT-PCR (Table 3).
A sequence analysis of the capsid coding region corresponding to the B-cell epitope of the
FMDV RNA directly recovered from the lesions were performed. A synonymous mutation
was found in animal 257 (B-cell epitope unchanged) and a nonsynonymous mutation in ani-
mal 264. In the latter, a valine was replace by an alanine at the 144 amino acid position, within
B-cell epitope (-1 RGD position)
Discussion
Synthetic peptides corresponding to protective B- and T-cell epitopes are considered good
candidates for safer and more effective FMD vaccines [29]. The group led by Dr. Mowat
reported in 1986 for the first and only time the successful protection against FMDV in cattle
[6]. The linear peptide spanning the VP1 regions (residues 141 to 158 and 200 to 213 of the
serotype O1, 40 residue peptide) synthesized collinearly, induces a neutralizing antibody
response and protected two out of three animals vaccinated with a single dose of peptide and
three all animals with a revaccination with low dose at 32 days post-vaccination. Nevertheless,
all subsequent studies of vaccination with linear peptides on this important FMDV natural
host and with a larger number of animals resulted in partial [7] or null protection [30]. Multi-
ple presentation of the B-cell epitope has been proven advantageous over simpler arrange-
ments when eliciting humoral and cellular immune responses [8]. Indeed, a dendrimer
peptide displaying four copies of the B cell epitope VP1 (136–154) and one copy of the T-cell
epitope 3A(21–40) from type C FMDV, assembled using a thioether conjugation chemistry
protects against homologous FMDV challenge in swine [3]. Recently, Blanco et al (2016)
Table 2. Cellular immune response of cattle at 44 dpv analyzed by lymphoproliferation and IFN-γ production.
Group Animal n˚ (A) % CFSE proliferation (B) IFN-γ (x102 pg/ml)
Ag: B2T B4T T Ag: B2T B4T T
B2T 256 13.0 8.0 5.0 226.7 151 90
257 15.0 16.0 20.0 119.7 143.4 85
264 4.2 5.1 2.5 37 20.4 0.5
267 2.0 1.0 1.0 6.8 4.7 2.9
268 6.1 ND 1.0 12.6 8.5 6.4
B4T 253 5.1 3.0 2.0 15.1 15.1 0.5
263 12.0 13 13 113.5 25.3 0.5
266 8.2 7.1 1.0 14.1 20.9 4.3
270 8.1 4.0 1.0 22.4 9.7 9.7
271 4.1 9.0 6.1 52.1 42.4 0.5
Negative control 254 2.0 2.0 1.0 0.5 5.3 1.7
(A) Specific proliferation of PBMC from vaccinated bovines measured by CFSE labeling, the results are expressed as % CFSE proliferation. PBMC were
stimulated in vitro with medium alone, or with peptides B2T, B4T, and T. For each peptide, the cut-off was calculated as the mean number of proliferating
cells at 0 dpv plus 2 SD. Positive %CFSE proliferations are underlined (4).
(B) IFN-γ production by PBMC after peptide stimulation as in (A). The supernatants were tested by ELISA and the results, expressed in pg/ml, were
calculated by interpolation in a cytokine standard curve. For each peptide, the cut-off was calculated as the mean IFN-γ production of PBMCs from animals
at day 0 plus 2 SD. Positive IFN-γ production above cut-off were underlined (11.0 x 102 pg/ml).
https://doi.org/10.1371/journal.pone.0185184.t002
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reported full protection in pigs vaccinated with the analogous dendrimer B2T with sequences
from type O FMDV O-UKG assembled using maleimide linkage, an advantageous conjugation
chemistry in terms of production simplicity, with positive impact in costs and adaptability [4].
Another important point to highlight is that synthetic peptide with low immunogenicity can
promote selection of viral escape mutants as they frequently include a single or a very limited
number of B cell neutralizing sites [7]. However, the use of dendrimeric peptides can over-
come this potential limitation as these structures allow the incorporation of different B cell epi-
topes into a single molecule.
Hence, the present report aimed to assess the effectiveness of novel maleimide-conjugated
dendrimeric peptides in cattle in affording protective immune responses to FMDV. These new
constructs displayed either two or four copies of the B-cell epitope (135–160 from VP1, type O
FMDV O1 Campos) and one T-cell epitope 21–40 from VP1 (named B2T and B4T, respec-
tively). Our results indicate that these two dendrimers afforded 100% PPG to viral challenge.
When compared with the immune response evoked by analogous dendrimers in swine, the
main difference observed in bovine is the need for a third immunization to detect consistent
levels of neutralizing antibodies. It is possible that the immunogenicity in cattle can be
increased by using other adjuvants or different amounts of peptide in the vaccine. Moreover,
after a third dose of vaccine containing a low amount of peptide, we observed an enhancement
of the IgG affinity rather than an increase on the level of IgGs. The third immunization could
have resulted into a more stringent selection of higher affinity B cells, and the emergence of
effective neutralizing antibodies.
In addition, pigs vaccinated with dendrimer B(OUK)2T3A elicited increased levels of virus-
specific IgG1 and IgG2 relative to those of animals vaccinated with B(OUK)4T3A, while in this
study immunization of cattle with B2T or B4T elicited similar levels of total anti-peptide and
anti-FMDV antibodies, as well as high levels of specific IgG1 against the virus. Further
Table 3. Clinical lesions and protection post challenge of vaccinated cattle.
Group Animal n˚ Lesions Protection
Foot Tongue
B2T 256 − − PPG
257 − +** PPG
264 − +** PPG
267 − − PPG
268 − − PPG
B4T 253 − − PPG
263 − − PPG
266 − − PPG
270 − − PPG
271 − − PPG
Negative control 254* + + NP
241* + + NP
261* + + NP
Animal with no lesions on the feet were protected against podal generalization (PPG) and animals with lesions on their feet before 7dpc were considered
non protected (NP).
* On day 2pc this animal exhibited at least a lesion in snout or mouth. At 7dpc, these animals showed FMDV lesions in the feet, and vesicles in the snout
and mouth.
**Positive amplification by RT-PCR of FMDV 3D RNA sequences in tongue epithelium.
https://doi.org/10.1371/journal.pone.0185184.t003
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experiments are required to understand the low levels of IgG2 detected in this study; notewor-
thy, the same nomenclature for subclasses among different species often leads to the mistaken
believe that these subclasses are homologous and have the same functions [31].
Induction of high levels of FMDV-specific IgG1 subtype in serum has been related to pro-
tection in conventionally vaccinated cattle, even at low levels of total IgG [32]. Furthermore,
differential IgG1/IgG2 ratios have been associated with protection in animals with low VNT
titers [33], as well as in bovines immunized with linear synthetic peptides [7]. Bovine IgG1 is
involved in neutralization and also in pathogen opsonization.
Macrophages have a high phagocytic capacity and they can engulf and destroy FMDV,
especially if it is opsonized by specific antibodies [27, 34]. At day 44dpv, high opsonophagocy-
tosis levels were found in sera from animals vaccinated with the dendrimeric constructs, with
values similar to those from bovines vaccinated with a commercial vaccine.
Animals of the B4T group were not only protected from podal generalization but also did
not develop lesions in tongue or mouth, near the viral instillation point, which could be related
with the trend towards higher opsonization and VNT values observed in sera of these animals
when compared with those immunized with B2T. One of the two B2T-vaccinated cattle that
developed tongue lesions (animal 264) showed an amino acid substitution in the region corre-
sponding to the B epitope, which could reflect the selection of a scape mutant in this partially
protected animal.
In animals immunized with B4T, VNT titers were similar to those of bovines immunized
with the commercial vaccine (approved by SENASA for vaccination in Argentina) and associ-
ated with Expected Percentage of Protection (EPP) of 80 percent. The EPP estimates the likeli-
hood that cattle would be protected against a challenge of 10.000 bovine infective doses after
vaccination [15]. Bovine 253 that elicited low neutralizing antibodies levels (1.2) resulted pro-
tected upon challenge, which could be associated with the presence of high IgG1 levels in its
serum, in accordance with the results published by Capozzo et al [32].
Importantly, all antibodies induced by the dendrimeric peptides used in this study allowed
differentiation of infected from vaccinated animals, since they did not react against the NS pro-
tein 3ABC (data not shown), which is the standard diagnostic tool for FMDV replication [35].
It is plausible that the improved immunogenicity of constructs with four versus two epi-
topes is based on positing repetitive antigens that induce direct cross-linking of surface Ig
receptors in immature B cells [36] or that epitope multimerization promotes antigen internali-
zation by dendritic cells or other antigen presenting cells [37]. In any case, B4T and B2T effi-
ciency in cattle differs from that described for their counterparts in pigs [4] and further
experiments are needed to understand these differences among dendrimers that display differ-
ent B and T cell sequences and target different species. The T-cell epitope VP1 (21–40), previ-
ously identified in bovine [11] was incorporated to B2T and B4T due to the lack of
experimental evidence supporting recognition as a T-helper epitope in cattle of the 3A (21–35)
epitope included in the dendrimers that successfully protected swine [4].
FMDV usually gains entry through the respiratory tract of cattle [38]. There are a number
of mechanisms that have been proposed to explain the production of secretory antibodies after
immunization with antigen. One of the mechanisms proposed is the direct diffusion of soluble
or phagocytosed antigens to mucosal-associated lymphatic tissues (MALT); other is the migra-
tion of activated antigen-presenting cells to MALT from the lymph node that drains the inocu-
lation site.[39, 40]. However, in mucosa, regulation of IgA and IgG1 production in cattle is not
completely understood and further studies should be aimed at establishing the association
between these immunoglobulins and protection. In animals belonging to B2T and B4T groups,
IgG1 specific against FMDV was increased in nasal secretions, suggesting some role of this
immunoglobulin in protection; however, only some animals showed an increased IgA in nasal
Protection of cattle by dendrimeric peptides
PLOS ONE | https://doi.org/10.1371/journal.pone.0185184 September 26, 2017 12 / 16
secretions. It is tentative to speculate the possible implications of both IgG1 and IgA immuno-
globulins against viral entry in mucosal tissues.
Animal to animal variation was observed in both the lymphoproliferation and IFN-γ secre-
tion assays, as reported in previous studies with peptide-immunized cattle [7]. Interestingly,
B2T and B4T peptides evoked similar consistent T cell responses, being recognized in vitro by
lymphocytes from most of the immunized cattle in the proliferation assay, and from all ani-
mals in the IFN-γ production assay. The T-cell epitope VP1(21–40] alone was recognized by a
lower number of peptide vaccinated bovines, and it was not as efficient inducing cellular
responses as B2T and B4T peptides, which could be due to a better presentation/processing of
the dendrimers in the in vitro assays used. On the other hand, it has been described that the
135–160 region of VP1 there is recognized as a T-cell epitope in bovine (135–144) [41].
The number of bovines included in this pilot study was similar to those in other introduc-
tory studies on vaccine candidates [4, 6, 42, 43], although we were aware that these numbers
are not enough for statistical demonstration [19].
In conclusion, our results support that immunization of cattle with dendrimeric peptides
such as B2T or B4T can evoke humoral immune responses similar to those induced by com-
mercial vaccines. More importantly, they were able to elicit protective responses preventing
clinical disease. These results supported our new dendrimeric peptide constructs as a promis-
ing candidate for peptide subunit DIVA vaccines against FMDV in cattle.
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